Skip to main content
. Author manuscript; available in PMC: 2024 Dec 11.
Published in final edited form as: Biochim Biophys Acta Mol Basis Dis. 2024 Mar 16;1870(5):167096. doi: 10.1016/j.bbadis.2024.167096

Fig. 8.

Fig. 8.

Nanoparticle tracking analysis of urinary EV (uEV) concentration and size. A. Concentration of uEVs isolated from urine samples collected during the active or inactive cycle of one week post-procedure sham control mice (SH W1 Active) or (SH W1 Inactive) and nephrectomized mice (NX W1 Active) or (NX W1 Inactive) and three week post-procedure sham control mice (SH W3 Active) or (SH W3 Inactive) and nephrectomized mice (NX W3 Active) or (NX W3 Inactive). B. Size of uEVs isolated from urine samples collected during the active or inactive cycle of one week post-procedure sham control mice (SH W1 Active) or (SH W1 Inactive) and nephrectomized mice (NX W1 Active) or (NX W1 Inactive) and three week post-procedure sham control mice (SH W3 Active) or (SH W3 Inactive) and nephrectomized mice (NX W3 Active) or (NX W3 Inactive). C. 24-h uEV concentration normalized to urinary creatinine D. 24-h uEV concentration normalized to kidney volume. ns represents no significant difference between the groups.